Similar Items: Regional amyloid PET asymmetry and long‐term clinical trajectory in mild cognitive impairment
- Identification of patients receiving amyloid‐targeting therapies in observational studies using amyloid PET trajectories: Insights from LEADS
- Refining cognitive dispersion metrics for brain–behavior prediction in aging and mild cognitive impairment
- A potential multimodal biomarker – cognitive signature associated with the conversion from subjective cognitive decline to mild cognitive impairment
- A combination of ketones and NAD+ precursor preserves white matter integrity in mild cognitive impairment
- Virtual reality-based cognitive assessment tools for mild cognitive impairment screening: comparison with traditional paper-and-pencil-based cognitive assessment tools
- Use of Wearable Technology for Measuring and Characterizing Sedentary Behavior in People With Mild Cognitive Impairment and Dementia: Systematic Review